\-\ Texto\\:\\ \ \(0\)\
\-\ slender\\,\\ elderly\\ male\\.\\ \\ no\\ abdominal\\ pain\\,\\ no\\ localized\\ symptoms\\.\ \(0\)\
\-\ in\\ this\\ older\\ patient\\ with\\ multiple\\ comorbidities\\ and\\ surgical\\ risk\\ factors\\,\\ periodic\\ monitoring\\ is\\ currently\\ planned\\.\ \(0\)\
\-\ lobulated\\ multicystic\\ lesion\\ which\\ involves\\ the\\ pancreatic\\ head\\ and\\ uncinate\\ process\\,\\ predominantly\\.\\ \\ the\\ main\\ pancreatic\\ duct\\ is\\ dilated\\ to\\ 10mm\\ and\\ there\\ is\\ also\\ branch\\ duct\\ involvement\\ within\\ the\\ pancreatic\\ body\\.\\ \\ no\\ mural\\ nodules\\ or\\ solid\\ masses\\ are\\ identified\\.\ \(0\)\
\-\ combined\\-type\\ intraductal\\ papillary\\ mucinous\\ neoplasm\ \(0\)\
\-\ \\‚\\Ä\\¢\\ chronic\\ pancreatitis\ \(0\)\
\-\ \\‚\\Ä\\¢\\ pancreatic\\ pseudocyst\ \(1\)\
\-\ \\‚\\Ä\\¢\\ mucinous\\ cystic\\ neoplasm\ \(0\)\
\-\ \\‚\\Ä\\¢\\ serous\\ cystadenoma\ \(1\)\
\-\ 79\\ y\\/o\\ white\\ male\\,\\ preoperative\\ evaluation\\ pending\\ cabg\\.\\ \\ history\\ of\\ hypertension\\,\\ hyperlipidemia\\ and\\ diabetes\\.\\ \\ recent\\ 50\\ lb\\ weight\\ loss\\.\ \(0\)\
\-\ intraductal\\ papillary\\ mucinous\\ neoplasm\\ \\(ipmn\\)\\,\\ also\\ referred\\ to\\ in\\ previous\\ literature\\ as\\ intraductal\\ papillary\\ mucinous\\ tumor\\ \\(ipmt\\)\\ is\\ a\\ low\\-grade\\ malignancy\\ that\\ arises\\ from\\ the\\ epithelial\\ lining\\ of\\ the\\ main\\ or\\ branch\\ pancreatic\\ ducts\\,\\ and\\ is\\ characterized\\ by\\ excessive\\ mucin\\ production\\.\\ \\ ipmn\\ is\\ classified\\ into\\ three\\ types\\:\\ branch\\ pancreatic\\ duct\\ type\\,\\ main\\ pancreatic\\ duct\\ type\\,\\ and\\ combined\\ type\\.\\ \\ combined\\ type\\ is\\ the\\ most\\ common\\.\ \(0\)\
\-\ ipmn\\ presents\\ clinically\\ with\\ diarrhea\\,\\ pain\\,\\ weight\\ loss\\,\\ acute\\ pancreatitis\\ and\\ diabetes\\.\\ \\ typical\\ age\\ of\\ onset\\ is\\ 60\\-80\\ y\\/o\\,\\ more\\ commonly\\ in\\ males\\.\ \(0\)\
\-\ ct\\ findings\\ for\\ branch\\ pancreatic\\ duct\\ type\\ include\\ a\\ thin\\,\\ irregular\\ and\\ peripheral\\ lobulated\\ multicystic\\ lesion\\ \\(\\‚\\Ä\\úgrape\\-like\\‚\\Ä\\ù\\ clusters\\)\\.the\\ main\\ pancreatic\\ duct\\ type\\ appears\\ as\\ a\\ markedly\\ dilated\\ and\\ tortuous\\ main\\ pancreatic\\ duct\\.\\ \\ polypoid\\ lesions\\ may\\ be\\ seen\\ lining\\ the\\ main\\ duct\\.\\ \\ the\\ combined\\ type\\ appears\\ as\\ a\\ multicystic\\ lesion\\ \\(commonly\\ within\\ the\\ uncinate\\ process\\)\\ which\\ is\\ contiguous\\ with\\ a\\ markedly\\ dilated\\ and\\ tortuous\\ main\\ pancreatic\\ duct\\.\\ mrcp\\ will\\ show\\ communication\\ between\\ the\\ dilated\\ duct\\ and\\ cystic\\ lesions\\.\ \(0\)\
\-\ the\\ differential\\ diagnosis\\ for\\ ipmn\\ includes\\ chronic\\ pancreatitis\\,\\ pancreatic\\ pseudocyst\\,\\ mucinous\\ cystic\\ neoplasm\\ and\\ serous\\ cystadenoma\\.\\ \\ this\\ patient\\ had\\ no\\ history\\ of\\ pancreatitis\\.\\ \\ \ \(0\)\
\-\ imaging\\ features\\ of\\ ipmn\\ with\\ invasive\\ carcinoma\\ may\\ include\\ mural\\ nodularity\\ or\\ solid\\ mass\\ measuring\\ 3\\-10\\ mm\\,\\ diffuse\\ or\\ multifocal\\ main\\ duct\\ involvement\\,\\ main\\ or\\ combined\\ duct\\ types\\,\\ main\\ pancreatic\\ duct\\ measuring\\ \\>\\ 10\\-15\\ mm\\,\\ branch\\ duct\\ type\\ measuring\\ \\>\\ 3\\ cm\\ or\\ mural\\ nodularity\\,\\ common\\ bile\\ duct\\ \\>\\ 15\\ mm\\,\\ or\\ evidence\\ of\\ metastases\\.\\ \\ generally\\,\\ main\\ duct\\ and\\ combined\\ duct\\ types\\ are\\ resected\\ in\\ good\\ surgical\\ candidates\\.\\ \\ branch\\ duct\\ type\\ ipmn\\ without\\ suggestion\\ of\\ invasive\\ carcinoma\\ may\\ be\\ monitored\\.\\ \\ although\\ all\\ ipmns\\ are\\ felt\\ to\\ have\\ malignant\\ potential\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ lim\\ jh\\,\\ et\\ al\\.\\ radiologic\\ spectrum\\ of\\ intraductal\\ papillary\\ mucinous\\ tumor\\ of\\ the\\ pancreas\\.\\ radiographics\\.\\ 2001\\.\\ 21\\(2\\)\\:323\\-40\\.\ \(0\)\
\-\ prasad\\ sr\\,\\ et\\ al\\.\\ intraductal\\ papillary\\ tumors\\ of\\ the\\ pancreas\\.\\ abdom\\ imaging\\.\\ 2003\\.\\ 28\\(3\\)\\:357\\-65\\.\ \(0\)\
\-\ taouli\\ b\\,\\ et\\ al\\.\\ \\ intraductal\\ papillary\\ mucinous\\ tumors\\ of\\ the\\ pancreas\\:\\ features\\ with\\ multimodality\\ imaging\\.\\ j\\ comput\\ assist\\ tomogr\\.\\ 2002\\.\\ 26\\(2\\)\\:223\\-31\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ duct\\:\\ 0\\.1356119523697703\ \(0\)\
\-\ pancreatic\\:\\ 0\\.10451973589342156\ \(0\)\
\-\ ipmn\\:\\ 0\\.08572181610976855\ \(0\)\
\-\ main\\:\\ 0\\.08417615709070236\ \(0\)\
\-\ mucinous\\:\\ 0\\.06901244767109219\ \(0\)\
\-\ intraductal\\:\\ 0\\.06553874086196941\ \(0\)\
\-\ branch\\:\\ 0\\.05337535017623161\ \(0\)\
\-\ papillary\\:\\ 0\\.050055941647941825\ \(0\)\
\-\ type\\:\\ 0\\.04985695779831191\ \(0\)\
\-\ combined\\:\\ 0\\.04539590251677306\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.036064492607087745\ \(0\)\
\-\ multicystic\\:\\ 0\\.0338716121815388\ \(0\)\
\-\ mural\\:\\ 0\\.028063123300298483\ \(0\)\
\-\ uncinate\\:\\ 0\\.026421570288119943\ \(0\)\
\-\ pancreas\\:\\ 0\\.025228079812362587\ \(0\)\
\-\ types\\:\\ 0\\.025160602659882635\ \(0\)\
\-\ dilated\\:\\ 0\\.0238853185122433\ \(0\)\
\-\ neoplasm\\:\\ 0\\.02238581981470714\ \(0\)\
\-\ serous\\:\\ 0\\.021846246953989804\ \(0\)\
\-\ lining\\:\\ 0\\.021682556129302123\ \(0\)\
\-\ pseudocyst\\:\\ 0\\.021229544453700653\ \(0\)\
\-\ al\\:\\ 0\\.02089939369082474\ \(0\)\
\-\ nodularity\\:\\ 0\\.0206981969980052\ \(0\)\
\-\ tortuous\\:\\ 0\\.0205760866198722\ \(0\)\
\-\ et\\:\\ 0\\.020177298635320858\ \(0\)\
\-\ measuring\\:\\ 0\\.019715513783358146\ \(0\)\
\-\ cystadenoma\\:\\ 0\\.019097580085601692\ \(0\)\
\-\ mm\\:\\ 0\\.01812804898150965\ \(0\)\
\-\ combined\\-type\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ ipmns\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ \\:323\\-40\\.\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ abdom\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ \\:357\\-65\\.\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ taouli\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ comput\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ tomogr\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ \\:223\\-31\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ lobulated\\:\\ 0\\.016514345565067146\ \(0\)\
\-\ invasive\\:\\ 0\\.016514345565067146\ \(0\)\
\-\ \\>\\:\\ 0\\.016379812584626334\ \(0\)\
\-\ diabetes\\:\\ 0\\.016271349789599716\ \(0\)\
\-\ slender\\:\\ 0\\.015619944698858756\ \(0\)\
\-\ prasad\\:\\ 0\\.015619944698858756\ \(0\)\
\-\ markedly\\:\\ 0\\.015557053075003206\ \(0\)\
\-\ ipmt\\:\\ 0\\.014840204106343055\ \(0\)\
\-\ grape\\-like\\:\\ 0\\.014840204106343055\ \(0\)\
\-\ \\.the\\:\\ 0\\.014840204106343055\ \(0\)\
\-\ 3\\-10\\:\\ 0\\.014840204106343055\ \(0\)\
\-\ multimodality\\:\\ 0\\.014840204106343055\ \(0\)\
\-\ lim\\:\\ 0\\.014286969351628093\ \(0\)\
\-\ cystic\\:\\ 0\\.014219034849529376\ \(0\)\
\-\ \\,\\:\\ 0\\.014056099555705307\ \(0\)\
\-\ features\\:\\ 0\\.013869354888942606\ \(0\)\
\-\ 60\\-80\\:\\ 0\\.01350722875911239\ \(0\)\
\-\ or\\:\\ 0\\.01348203700528068\ \(0\)\
\-\ sr\\:\\ 0\\.013210785144059971\ \(0\)\
\-\ solid\\:\\ 0\\.013109025586563\ \(0\)\
\-\ comorbidities\\:\\ 0\\.01272748816659669\ \(0\)\
\-\ process\\:\\ 0\\.012654098018595057\ \(0\)\
\-\ clusters\\:\\ 0\\.01252487179033164\ \(0\)\
\-\ commonly\\:\\ 0\\.012402044013290928\ \(0\)\
\-\ tumors\\:\\ 0\\.012345062914117312\ \(0\)\
\-\ candidates\\:\\ 0\\.012341582983015631\ \(0\)\
\-\ appears\\:\\ 0\\.012233572387681727\ \(0\)\
\-\ \\‚\\Ä\\¢\\:\\ 0\\.012053956550737599\ \(0\)\
\-\ involvement\\:\\ 0\\.012045917910106988\ \(0\)\
\-\ mrcp\\:\\ 0\\.012020325127894157\ \(0\)\
\-\ 10mm\\:\\ 0\\.011877809796829307\ \(0\)\
\-\ jh\\:\\ 0\\.011877809796829307\ \(0\)\
\-\ weight\\:\\ 0\\.011780560712080251\ \(0\)\
\-\ mucin\\:\\ 0\\.011745131197815938\ \(0\)\
\-\ imaging\\:\\ 0\\.011550425910320785\ \(0\)\
\-\ lb\\:\\ 0\\.011504432845981313\ \(0\)\
\-\ assist\\:\\ 0\\.011290537393846266\ \(0\)\
\-\ polypoid\\:\\ 0\\.011191896443100976\ \(0\)\
\-\ 10\\-15\\:\\ 0\\.011191896443100976\ \(0\)\
\-\ cabg\\:\\ 0\\.011008607635784966\ \(0\)\
\-\ may\\:\\ 0\\.010813432897489176\ \(0\)\
\-\ classified\\:\\ 0\\.010762774229035188\ \(0\)\
\-\ periodic\\:\\ 0\\.010477351142269277\ \(0\)\
\-\ 79\\:\\ 0\\.010477351142269277\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.010171457498750648\ \(0\)\
\-\ preoperative\\:\\ 0\\.010061537472135363\ \(0\)\
\-\ low\\-grade\\:\\ 0\\.010061537472135363\ \(0\)\
\-\ lesion\\:\\ 0\\.010041664765387238\ \(0\)\
\-\ epithelial\\:\\ 0\\.010008847137158218\ \(0\)\
\-\ excessive\\:\\ 0\\.009957562046615602\ \(0\)\
\-\ production\\:\\ 0\\.009957562046615602\ \(0\)\
\-\ suggestion\\:\\ 0\\.009957562046615602\ \(0\)\
\-\ monitored\\:\\ 0\\.009907609188147794\ \(0\)\
\-\ arises\\:\\ 0\\.009858921095870311\ \(0\)\
\-\ is\\:\\ 0\\.009731955779735636\ \(0\)\
\-\ \\(\\:\\ 0\\.009724100160975045\ \(0\)\
\-\ elderly\\:\\ 0\\.009675632288554302\ \(0\)\
\-\ communication\\:\\ 0\\.009632415258069574\ \(0\)\
\-\ radiographics\\:\\ 0\\.009632415258069574\ \(0\)\
\-\ \\)\\:\\ 0\\.009605315086140646\ \(0\)\
\-\ loss\\:\\ 0\\.009540246817186307\ \(0\)\
\-\ spectrum\\:\\ 0\\.0095083027174204\ \(0\)\
\-\ males\\:\\ 0\\.009468650242030523\ \(0\)\
\-\ contiguous\\:\\ 0\\.009468650242030523\ \(0\)\
\-\ ducts\\:\\ 0\\.009429798881804523\ \(0\)\
\-\ planned\\:\\ 0\\.009354374433432828\ \(0\)\
\-\ carcinoma\\:\\ 0\\.009315106423137948\ \(0\)\
\-\ chronic\\:\\ 0\\.009257652434257692\ \(0\)\
\-\ include\\:\\ 0\\.009219821107808796\ \(0\)\
\-\ y\\/o\\:\\ 0\\.009102419345460157\ \(0\)\
\-\ monitoring\\:\\ 0\\.009079180503354612\ \(0\)\
\-\ 2002\\:\\ 0\\.008985353264567243\ \(0\)\
\-\ literature\\:\\ 0\\.008838482151519984\ \(0\)\
\-\ multifocal\\:\\ 0\\.008838482151519984\ \(0\)\
\-\ lesions\\:\\ 0\\.008798309639784415\ \(0\)\
\-\ bile\\:\\ 0\\.008782736888302192\ \(0\)\
\-\ 2001\\:\\ 0\\.008728562124904698\ \(0\)\
\-\ common\\:\\ 0\\.008601027738293835\ \(0\)\
\-\ radiologic\\:\\ 0\\.00855013571442207\ \(0\)\
\-\ diarrhea\\:\\ 0\\.008525945748639647\ \(0\)\
\-\ older\\:\\ 0\\.008278190225864708\ \(0\)\
\-\ 2003\\:\\ 0\\.008257172782533573\ \(0\)\
\-\ characterized\\:\\ 0\\.008175327370189736\ \(0\)\
\-\ resected\\:\\ 0\\.008135674894799858\ \(0\)\
\-\ localized\\:\\ 0\\.00800299629578649\ \(0\)\
\-\ potential\\:\\ 0\\.00791353472725785\ \(0\)\
\-\ 28\\:\\ 0\\.007746205156123948\ \(0\)\
\-\ b\\:\\ 0\\.007746205156123948\ \(0\)\
\-\ felt\\:\\ 0\\.007730245919941841\ \(0\)\
\-\ predominantly\\:\\ 0\\.007698719362680924\ \(0\)\
\-\ 3\\:\\ 0\\.007696059718102076\ \(0\)\
\-\ tumor\\:\\ 0\\.007662431929272351\ \(0\)\
\-\ involves\\:\\ 0\\.007637175649053668\ \(0\)\
\-\ 26\\:\\ 0\\.007607126960778512\ \(0\)\
\-\ as\\:\\ 0\\.007457177918619968\ \(0\)\
\-\ 21\\:\\ 0\\.007436074103054481\ \(0\)\
\-\ j\\:\\ 0\\.007422483396856226\ \(0\)\
\-\ generally\\:\\ 0\\.0073955867776740345\ \(0\)\
\-\ factors\\:\\ 0\\.007382278233742161\ \(0\)\
\-\ clinically\\:\\ 0\\.007205027349512052\ \(0\)\
\-\ pending\\:\\ 0\\.007110624252980276\ \(0\)\
\-\ 2\\:\\ 0\\.0070773249865790245\ \(0\)\
\-\ good\\:\\ 0\\.0070316598552922485\ \(0\)\
\-\ metastases\\:\\ 0\\.00702063932700574\ \(0\)\
\-\ surgical\\:\\ 0\\.006908545270197899\ \(0\)\
\-\ references\\:\\ 0\\.006832361990503102\ \(0\)\
\-\ nodules\\:\\ 0\\.0068125362796206766\ \(0\)\
\-\ thin\\:\\ 0\\.006754256761360429\ \(0\)\
\-\ are\\:\\ 0\\.00672042618767078\ \(0\)\
\-\ includes\\:\\ 0\\.006624769991997761\ \(0\)\
\-\ no\\:\\ 0\\.0066188011592600154\ \(0\)\
\-\ typical\\:\\ 0\\.006589320565673072\ \(0\)\
\-\ irregular\\:\\ 0\\.0065545127932815\ \(0\)\
\-\ 15\\:\\ 0\\.0065545127932815\ \(0\)\
\-\ \\:\\:\\ 0\\.006520816246099991\ \(0\)\
\-\ currently\\:\\ 0\\.006511870759638572\ \(0\)\
\-\ also\\:\\ 0\\.006479306129500583\ \(0\)\
\-\ hypertension\\:\\ 0\\.006478425100577285\ \(0\)\
\-\ previous\\:\\ 0\\.006381442689756339\ \(0\)\
\-\ malignancy\\:\\ 0\\.006350172457310608\ \(0\)\
\-\ within\\:\\ 0\\.0062697361861003146\ \(0\)\
\-\ 50\\:\\ 0\\.006251919262776548\ \(0\)\
\-\ referred\\:\\ 0\\.006201022006645464\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.006137501764959923\ \(0\)\
\-\ which\\:\\ 0\\.006135171489394418\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.006103098755823816\ \(0\)\
\-\ risk\\:\\ 0\\.005952320475690551\ \(0\)\
\-\ peripheral\\:\\ 0\\.005946025619257918\ \(0\)\
\-\ male\\:\\ 0\\.005943098222644128\ \(0\)\
\-\ malignant\\:\\ 0\\.005939751300729426\ \(0\)\
\-\ identified\\:\\ 0\\.005872052002281388\ \(0\)\
\-\ masses\\:\\ 0\\.005554985380761706\ \(0\)\
\-\ although\\:\\ 0\\.005549864001108853\ \(0\)\
\-\ three\\:\\ 0\\.005539661977590212\ \(0\)\
\-\ recent\\:\\ 0\\.005524459709307303\ \(0\)\
\-\ white\\:\\ 0\\.0054502004090615725\ \(0\)\
\-\ body\\:\\ 0\\.005337045601325163\ \(0\)\
\-\ differential\\:\\ 0\\.005217230441063326\ \(0\)\
\-\ between\\:\\ 0\\.0052086452619697\ \(0\)\
\-\ onset\\:\\ 0\\.005187348511394519\ \(0\)\
\-\ will\\:\\ 0\\.005141309650729119\ \(0\)\
\-\ be\\:\\ 0\\.005068295089784343\ \(0\)\
\-\ show\\:\\ 0\\.005044530643253127\ \(0\)\
\-\ age\\:\\ 0\\.005001750626046743\ \(0\)\
\-\ diffuse\\:\\ 0\\.004975014269952529\ \(0\)\
\-\ evaluation\\:\\ 0\\.004773536145820784\ \(0\)\
\-\ head\\:\\ 0\\.0046607717511036465\ \(0\)\
\-\ all\\:\\ 0\\.004647929787367867\ \(0\)\
\-\ history\\:\\ 0\\.004539286683488783\ \(0\)\
\-\ and\\:\\ 0\\.004500225143305461\ \(0\)\
\-\ cm\\:\\ 0\\.004407607918878819\ \(0\)\
\-\ evidence\\:\\ 0\\.004308543429551688\ \(0\)\
\-\ more\\:\\ 0\\.004109954440984935\ \(0\)\
\-\ abdominal\\:\\ 0\\.0041075369963886835\ \(0\)\
\-\ symptoms\\:\\ 0\\.004095495147881037\ \(0\)\
\-\ acute\\:\\ 0\\.004057460248281722\ \(0\)\
\-\ pain\\:\\ 0\\.004013877567425903\ \(0\)\
\-\ into\\:\\ 0\\.003910243015307129\ \(0\)\
\-\ without\\:\\ 0\\.0038692560891503084\ \(0\)\
\-\ a\\:\\ 0\\.0038134596328711664\ \(0\)\
\-\ most\\:\\ 0\\.0037939137340924542\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0037734987130392693\ \(0\)\
\-\ the\\:\\ 0\\.0037220961266360795\ \(0\)\
\-\ this\\:\\ 0\\.0036966815896697426\ \(0\)\
\-\ have\\:\\ 0\\.0035585347660867152\ \(0\)\
\-\ had\\:\\ 0\\.003545865037001362\ \(0\)\
\-\ findings\\:\\ 0\\.003497763338057615\ \(0\)\
\-\ multiple\\:\\ 0\\.0034611653913062864\ \(0\)\
\-\ presents\\:\\ 0\\.0033570082605921653\ \(0\)\
\-\ patient\\:\\ 0\\.0032945843496784153\ \(0\)\
\-\ seen\\:\\ 0\\.0032473607982070967\ \(0\)\
\-\ in\\:\\ 0\\.0032415171549250383\ \(0\)\
\-\ that\\:\\ 0\\.0028384244779977373\ \(0\)\
\-\ for\\:\\ 0\\.0028042621101642892\ \(0\)\
\-\ by\\:\\ 0\\.0027362901985478363\ \(0\)\
\-\ \\.\\:\\ 0\\.002525928530003485\ \(0\)\
\-\ of\\:\\ 0\\.002464503478418986\ \(0\)\
\-\ to\\:\\ 0\\.0024638544717864594\ \(0\)\
\-\ there\\:\\ 0\\.0024456068393557476\ \(0\)\
\-\ from\\:\\ 0\\.0024354532945273315\ \(0\)\
\-\ ct\\:\\ 0\\.002298660871907775\ \(0\)\
\-\ mass\\:\\ 0\\.002285501936437624\ \(0\)\
\-\ with\\:\\ 0\\.0011250401547104783\ \(0\)\
